Archive — US — techcrunch
23andMe faces an uncertain future — so does your genetic data
23andMe faces a precarious future following a significant data breach and financial losses, jeopardizing the privacy of its 15 million customers' genetic data. With a 99% drop in value since going public, potential bankruptcy looms, and concerns rise over data privacy as the company considers selling off assets, including sensitive DNA information, amidst calls for customers to proactively delete their accounts.
Key points
- 23andMe suffered a data breach in 2023, compromising the genetic data of nearly 7 million users.
- The company's stock value dropped over 99% after failing to become profitable, leading to financial turmoil.
- Founder and CEO Anne Wojcicki considered a sale or privatization, which prompted the resignation of independent board members.
- 23andMe's privacy policies allow for customer data to be sold or transferred during bankruptcy or acquisition.
- Privacy advocates warn customers of the risks involved if the company is sold to organizations with ties to law enforcement.
Why it matters
- The case highlights growing concerns about genetic data privacy amid a trend towards stricter data regulations and consumer rights.
- As of 2025, issues surrounding data ownership and privacy rights continue to garner attention, especially after high-profile breaches across various sectors.
- The debate over how genetic data should be treated and regulated is mirrored in ongoing discussions about AI and personal data use.
23andMe's situation underscores the urgent need for robust regulations on genetic data protection. As the company contemplates bankruptcy, customers are advised to consider the implications of their data and take proactive steps to safeguard their privacy.